Impact and Control of Drug Therapy Guidelines for Tumor Patients During the Novel Coronavirus Pneumonia Epidemic
Razi Ahmed1, Shafiza Mohd Shariff1, Shahrinaz Ismail1, Anwer Irshad Burney2 & Nawaf Waqas1 Show affiliations
- Universiti Kuala Lumpur, Malaysia
- The Millennium University, Pakistan
Journal of Computer Science, Volume 17, Issue 8, pp. 738–747 · doi.org/10.3844/jcssp.2021.738.747
Abstract
Since December 2019, many unexplained viral pneumonia cases have been found in Wuhan City, Hubei Province, China. It was later confirmed that the outbreak's causative agent was a new coronavirus. The virus was temporarily named "2019-new coronavirus" (2019-nCoV) by the World Health Organization (WHO). The diseases caused by 2019-nCoV were called by the National Health and Health Commission of China "New coronavirus pneumonia" (Novel Coronavirus Pneumonia, NCP) and was named "Coronavirus disease 2019" (COVID-19) by the WHO. The outbreak of NCP seriously affected the lives of the public. This article focuses on the group of cancer patients, comprehensively considers the social, medical resources and family issues to analyze the possible impact of the epidemic on cancer patients' drug treatment and health and makes recommendations for cancer patients' management.
Licence and reuse
Open access. This article is licensed under a Creative Commons Attribution 4.0 International Licence (CC BY 4.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.
How to reuse this articleResponses (0)
About this article
Ahmed, R., Shariff, S. M., Ismail, S., Burney, A. I. & Waqas, N. (2021). Impact and Control of Drug Therapy Guidelines for Tumor Patients During the Novel Coronavirus Pneumonia Epidemic. Journal of Computer Science, 17(8), 738–747. https://doi.org/10.3844/jcssp.2021.738.747
- Licence
- CC BY 4.0
- Issue
- Volume 17, Issue 8
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
